The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
28 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $17,136,716 in first-year total cost, median $585,583.
Most frequent study sections
- Vaccines Against Microbial Diseases Study Section[VMD]8
- Immunity and Host Defense Study Section[IHD]4
- Cellular and Molecular Immunology - A Study Section[CMIA]2
- Genetic Variation and Evolution Study Section[GVE]2
- Innate Immunity and Inflammation Study Section[III]2
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL4
- DUKE UNIVERSITY2
- GEORGIA STATE UNIVERSITY2
- ST. JUDE CHILDREN'S RESEARCH HOSPITAL2
- UNIVERSITY OF MISSOURI-COLUMBIA2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Selecting HA glycosylation for improved vaccine responses1R01AI155975-01A1 | WAN, XIUFENG HENRYWOODS, ROBERT JZAIA, JOSEPH | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $821,674 | VMD |
| 2021 | Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface1R01AI155804-01A1 | AZOITEI, MIHAI LUCHIAN | DUKE UNIVERSITY, NC | $812,575 | CMIA |
| 2021 | Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection1R01AI154458-01A1 | KOHUT, MARIAN LNARASIMHAN, BALAJI | IOWA STATE UNIVERSITY, IA | $729,805 | VMD |
| 2021 | Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells1R01AI158516-01A1 | JOST, STEPHANIEREEVES, ROGER KEITH | DUKE UNIVERSITY, NC | $662,843 | ZRG1 |
| 2021 | Synthetic multi-component influenza vaccines to elicit broad immunity1R56AI158743-01 | BOONS, GEERT-JANTOMPKINS, STEPHEN MARK | UNIVERSITY OF GEORGIA, GA | $562,640 | SBCA |
| 2021 | Innate immune signaling and stress response2R01AI124346-06 | KANNEGANTI, THIRUMALA-DEVI | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $538,500 | III |
| 2021 | Seasonal and universal Vaccination in aged populations with pre-existing immunity1R01AI154656-01A1 | KANG, SANG-MOO | GEORGIA STATE UNIVERSITY, GA | $501,999 | VMD |
| 2021 | A new mucosal adjuvant for augmenting influenza vaccines in elderly1R01AI153528-01A1 | WU, MEI X | MASSACHUSETTS GENERAL HOSPITAL, MA | $482,747 | IHD |
| 2020 | Universal T cell targeted influenza vaccine1R01AI130190-01A1 | HOFT, DANIEL F. | SAINT LOUIS UNIVERSITY, MO | $796,383 | ZRG1 |
| 2020 | Impact of repeated vaccination on the effectiveness of seasonal influenza vaccines1R01AI152521-01 | WAN, XIUFENG HENRY | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $758,514 | VMD |
| 2020 | Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants1R01AI146059-01A1 | ALEXANDER-MILLER, MARTHA ANN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $754,126 | ZRG1 |
| 2020 | Evolution and Transmission of Influenza Virus in Natural Human Infection1R01AI148371-01A1 | LAURING, ADAMMARTIN, EMILY TOTH | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $746,786 | GVE |
| 2020 | The role of ACE2 in Influenza viral infection mediated immune compromise and subsequent bacterial lung infection1R01AI148446-01A1 | JIA, HONGPENG | JOHNS HOPKINS UNIVERSITY, MD | $715,493 | LCMI |
| 2020 | Optimizing a Universal Influenza Subunit Nano/Microparticulate Vaccine1R01AI147497-01A1 | AINSLIE, KRISTY M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $604,292 | NANO |
| 2020 | Defining the Fc-correlates of protection against influenza1R01AI146785-01A1 | ALTER, GALIT | MASSACHUSETTS GENERAL HOSPITAL, MA | $544,875 | III |
| 2020 | Roles of tissue-resident helper T cells in mucosal immunity against influenza infection1R01AI154598-01 | SUN, JIE | MAYO CLINIC ROCHESTER, MN | $515,015 | ZRG1 |
| 2020 | Biomimetic nanoparticles to enhance the breadth of influenza vaccines1R01AI146588-01A1 | WU, MEI X | MASSACHUSETTS GENERAL HOSPITAL, MA | $445,294 | IHD |
| 2020 | Small viral RNAs as determinants of influenza A virus pathogenesis1R01AI145882-01A1 | TENOEVER, BENJAMIN R. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $423,750 | VIRA |
| 2020 | DC-subset-tailored vaccines1R01AI146420-01A1 | IGYARTO, BOTOND Z | THOMAS JEFFERSON UNIVERSITY, PA | $390,000 | CMIB |
| 2019 | Development of vaccination strategies to elicit broadly protective immunity against influenza1R01AI145870-01 | PALESE, PETERRAVETCH, JEFFREY VICTOR | ROCKEFELLER UNIVERSITY, NY | $864,833 | VMD |
| 2019 | Effects of obesity on the dynamics of Influenza transmission1R01AI140766-01A1 | GHEDIN, ELODIESCHULTZ-CHERRY, STACEY L | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $769,323 | VIRB |
| 2019 | Novel Influenza nano vaccines for broad cross protection2R01AI101047-06A1 | WANG, BAOZHONG | GEORGIA STATE UNIVERSITY, GA | $664,253 | VMD |
| 2019 | Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA1R01AI146101-01 | PARDI, NORBERT | UNIVERSITY OF PENNSYLVANIA, PA | $640,818 | VMD |
| 2019 | Use of Clinical Samples to Identify Influenza Virus Antigenic Variants1R01AI147640-01 | WAN, XIUFENG HENRY | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $566,874 | GVE |
| 2019 | FcRn-Targeted Mucosal Vaccination Against Influenza Infections1R01AI146063-01 | ZHU, XIAOPING | UNIV OF MARYLAND, COLLEGE PARK, MD | $554,124 | VMD |
| 2019 | B-1 cells, IgM and Protective Humoral Immunity to Influenza1R01AI148652-01 | BAUMGARTH, NICOLE | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $457,282 | IHD |
| 2019 | Epitope focusing by molecular grafting of subdominant epitopes to achieve a universal-influenza vaccine1R01AI146779-01 | SCHMIDT, AARON GREGORY | MASSACHUSETTS GENERAL HOSPITAL, MA | $408,458 | CMIA |
| 2019 | Strategies to enhance mucosal vaccination1R56AI146434-01 | SUN, WEI | ALBANY MEDICAL COLLEGE, NY | $403,440 | IHD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.